In the media 20 Nov 2024 Les enfants, grands oubliés de la recherche contre les maladies tropicales négligées Le Monde
Scientific articles 12 Nov 2024 Development and validation of ultra-performance liquid chromatography tandem mass spectrometry methods for the quantitative analysis of the antiparasitic drug DNDI-6148 in human plasma and various mouse biomatrices Journal of Chromatography B
Scientific articles 9 Nov 2024 Changes in lipid abundance are associated with disease progression and treatment response in chronic Trypanosoma cruzi infection Parasites Vectors
Viewpoints 7 Nov 2024 What the G20 Coalition for Local and Regional Production, Innovation, and Equitable Access should do next
Press releases 31 Oct 2024 DNDi welcomes new G20 coalition focused on innovation, local and regional production, and equitable access to health tools
Statements 30 Oct 2024 DNDi interventions at the 5th Meeting of the G20 Health Working Group and G20 Health Ministerial Meeting, 30-31 October 2024
Publications 29 Oct 2024 The Science Explained: Evaluating an alternative treatment regimen for fungal mycetoma
Scientific articles 22 Oct 2024 Climate change, migration, and health: perspectives from Latin America and the Caribbean The Lancet Regional Health – Americas
Scientific articles 17 Oct 2024 Immunotherapeutic strategies as potential treatment options for cutaneous leishmaniasis Vaccines
In the media 17 Oct 2024 ¿Dónde están los fondos para las enfermedades que atacan a mil millones de pobres? El País
Press releases 31 Oct 2024 DNDi welcomes new G20 coalition focused on innovation, local and regional production, and equitable access to health tools
Press releases 17 Jul 2024 Clinical trial in Eastern Africa finds a shorter, safer, and more effective treatment for PKDL, a stigmatizing skin disease
Press releases 1 Jul 2024 WHO recommends first all-oral treatment for acute sleeping sickness found in Eastern and Southern Africa
Press releases 24 Jun 2024 Paediatric malaria treatment developed in Brazil by not-for-profit organizations distributed to Indigenous children in the Amazon region
Press releases 12 Jun 2024 New framework for visceral leishmaniasis elimination launched for Eastern Africa
Press releases 9 May 2024 DNDi welcomes GHIT Fund’s renewed support to optimize novel compounds to treat Chagas disease
Press releases 23 Apr 2024 Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia
Press releases 3 Apr 2024 DNDi signs memorandum of understanding with Kenya Medical Research Institute
Press releases 30 Jan 2024 DNDi receives USD 20 million to develop innovative treatments to further elimination goals for sleeping sickness and river blindness
Press releases 10 Jan 2024 Clinical trial confirms the tolerability of the drug fexinidazole in the treatment of Chagas disease
Press releases 15 Dec 2023 EMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found in East and Southern Africa
Press releases 8 Dec 2023 Nagasaki University, DNDi, and GHIT Fund sign agreement to collaborate on drug screening for Chagas disease
Press releases 5 Dec 2023 Cryptococcal meningitis: new report highlights slow uptake of guidelines shown to reduce deaths in Africa
Press releases 3 Dec 2023 Germany’s Federal Ministry for Economic Cooperation and Development (BMZ) through KfW grants funding to fast-track access to medicines for poverty-related and neglected diseases
Press releases 23 Nov 2023 World’s first clinical trial for devastating fungal disease mycetoma shows efficacy of new, promising treatment
Press releases 16 Oct 2023 DNDi signs memorandum of understanding with Spanish Agency for International Development Cooperation